Exclusive

Publication

Byline

Location

US Patent Issued to VIVALDI BIOSCIENCES on Aug. 18 for "Influenza virus encoding a truncated NS1 protein and a SARS-CoV receptor binding domain" (Austrian, American Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,663, issued on Aug. 18, was assigned to VIVALDI BIOSCIENCES INC. (Fort Collins, Colo.). "Influenza virus encoding a truncated NS1 protein a... Read More


US Patent Issued to argenx on Aug. 18 for "Methods of treating paraproteinemic neuropathy with anti-C2 antibodies" (Dutch, Belgian Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,664, issued on Aug. 18, was assigned to argenx BV (Ghent, Belgium). "Methods of treating paraproteinemic neuropathy with anti-C2 antibodies... Read More


US Patent Issued to Beth Israel Deaconess Medical Center on Aug. 18 for "Anti-IL-1Beta antibody therapy in arrhythmogenic cardiomyopathy (ACM)" (Massachusetts Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,665, issued on Aug. 18, was assigned to Beth Israel Deaconess Medical Center Inc. (Boston). "Anti-IL-1Beta antibody therapy in arrhythmogen... Read More


US Patent Issued to Regeneron Pharmaceuticals, Sanofi Biotechnology on Aug. 18 for "Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist" (New York, New Jersey, Connecticut, Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,666, issued on Aug. 18, was assigned to Regeneron Pharmaceuticals Inc and Sanofi Biotechnology (Paris). "Methods for treating allergy and e... Read More


US Patent Issued to The University of Chicago on Aug. 18 for "Compositions and methods concerning combinations of immunologic inhibitors for the treatment of cancer" (Illinois Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,667, issued on Aug. 18, was assigned to The University of Chicago (Chicago). "Compositions and methods concerning combinations of immunolog... Read More


US Patent Issued to Pfizer on Aug. 18 for "Stable aqueous anti-TFPI antibody formulation" (Massachusetts, Kansas Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,668, issued on Aug. 18, was assigned to Pfizer Inc. (New York). "Stable aqueous anti-TFPI antibody formulation" was invented by Thomas Jose... Read More


US Patent Issued to ATRIUM THERAPEUTICS on Aug. 18 for "Polynucleotide conjugates comprising PLN -targeting anti-transferrin receptor antibodies and method of use thereof to treat PLN -associated cardiomyopathies" (California Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,669, issued on Aug. 18, was assigned to ATRIUM THERAPEUTICS INC. (San Diego). "Polynucleotide conjugates comprising PLN -targeting anti-tra... Read More


US Patent Issued to University of Georgia Research Foundation on Aug. 18 for "Methods of making targeted vesicles, and compositions made thereby" (Georgia Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,670, issued on Aug. 18, was assigned to University of Georgia Research Foundation Inc. (Athens, Ga.). "Methods of making targeted vesicles,... Read More


US Patent Issued on Aug. 18 for "Nanometric pharmaceutical composition in the form of liposomes or nanoemulsion containing specific sequences of interference RNA" (Brazilian Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,671, issued on Aug. 18. "Nanometric pharmaceutical composition in the form of liposomes or nanoemulsion containing specific sequences of in... Read More


US Patent Issued to Innovative Cellular Therapeutics Holdings, Innovative Cellular Therapeutics on Aug. 18 for "Vaccine and uses thereof in cell therapy" (Chinese, American Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,672, issued on Aug. 18, was assigned to Innovative Cellular Therapeutics Holdings Ltd. (George Town, Cayman Islands) and Innovative Cellular... Read More